China National Medicines Corporation Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 11,226.3 million compared to CNY 11,060.1 million a year ago. Revenue was CNY 11,226.3 million compared to CNY 11,060.1 million a year ago.

Net income was CNY 414.43 million compared to CNY 373.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.5493 compared to CNY 0.4955 a year ago. Diluted earnings per share from continuing operations was CNY 0.5493 compared to CNY 0.4955 a year ago.